![Victoria Vakiener](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Victoria Vakiener
Direktor/Vorstandsmitglied bei
ARROWHEAD PHARMACEUTICALS, INC.
Vermögen: 3 Mio $ am 31.07.2026
Profil
Victoria Vakiener is an Independent Director at Arrowhead Pharmaceuticals, Inc. since 2022.
Former roles include Independent Director at Chimerix, Inc. from 2021 to 2025, Vice President at Janssen Pharmaceuticals, Inc. from 2018 to 2020, Chief Commercial Officer at Epizyme, Inc. from 2020 to 2021, and Vice President-Oncology Marketing at Janssen Oncology, Inc. from 2014 to 2018.
Education includes undergraduate studies at Albright College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.01.2026 | 35’723 ( 0.03% ) | 3 Mio $ | 31.07.2026 |
Aktive Positionen von Victoria Vakiener
| Unternehmen | Position | Beginn |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 02.05.2022 |
Ehemalige bekannte Positionen von Victoria Vakiener
| Unternehmen | Position | Ende |
|---|---|---|
| CHIMERIX, INC. | Direktor/Vorstandsmitglied | 21.04.2025 |
| EPIZYME, INC. | Corporate Officer/Principal | 01.10.2021 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01.09.2020 |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Corporate Officer/Principal | 01.12.2018 |
Ausbildung von Victoria Vakiener
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Albright College
 Albright College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
